|
Paumard-Hernández B, Calvete O, Inglada Pérez L, Tejero H, Al-Shahrour F, Pita G, Barroso A, Carlos Triviño J, Urioste M, Valverde C, González Billalabeitia E, Quiroga V, Francisco Rodríguez Moreno J, Fernández Aramburo A, López C, Maroto P, Sastre J, José Juan Fita M, Duran I, Lorenzo-Lorenzo I, Iranzo P, García Del Muro X, Ros S, Zambrana F, María Autran A, Benítez J. Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer. Int J Cancer. 2018 Oct 15;143(8):1954-1962. doi: 10.1002/ijc.31604. Epub 2018 Aug 9. PubMed PMID: 29761480.
AÑO: 2018; IF: 4.982
|
29761480
|
Méndez-Vidal M.J., Molina Á., Anido U., Chirivella I., Etxaniz O., Fernández-Parra E., Guix M., Hernández C., Lambea J., Montesa Á., Pinto Á., Ros S., Gallardo E. Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma. BMC Pharmacology and Toxicology. 26 November 2018. 19. 10.1186/s40360-018-0264-8
AÑO: 2018; IF: 2.103
|
|
Sánchez Henarejos P, Ros Martínez S, Marín Zafra GR, Alonso Romero JL, Navarrete Montoya A. Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD). Clin Transl Oncol. 2009 Jul;11(7):486-7. PubMed PMID: 19574209.
AÑO: 2009; IF: 1.146
|